TECH vs. MRNA
Compare and contrast key facts about Bio-Techne Corporation (TECH) and Moderna, Inc. (MRNA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TECH or MRNA.
Correlation
The correlation between TECH and MRNA is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TECH vs. MRNA - Performance Comparison
Key characteristics
TECH:
-0.59
MRNA:
-1.10
TECH:
-0.69
MRNA:
-2.24
TECH:
0.92
MRNA:
0.73
TECH:
-0.39
MRNA:
-0.80
TECH:
-1.52
MRNA:
-1.25
TECH:
16.17%
MRNA:
60.99%
TECH:
41.55%
MRNA:
69.06%
TECH:
-74.39%
MRNA:
-94.94%
TECH:
-63.65%
MRNA:
-94.90%
Fundamentals
TECH:
$7.90B
MRNA:
$9.74B
TECH:
$0.98
MRNA:
-$9.28
TECH:
1.05
MRNA:
0.00
TECH:
6.61
MRNA:
3.01
TECH:
3.80
MRNA:
0.89
TECH:
$892.59M
MRNA:
$3.06B
TECH:
$581.78M
MRNA:
$1.65B
TECH:
$242.73M
MRNA:
-$2.27B
Returns By Period
In the year-to-date period, TECH achieves a -33.14% return, which is significantly higher than MRNA's -40.56% return.
TECH
-33.14%
-21.01%
-32.33%
-22.35%
-1.63%
7.38%
MRNA
-40.56%
-25.83%
-54.32%
-75.77%
-12.03%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TECH vs. MRNA — Risk-Adjusted Performance Rank
TECH
MRNA
TECH vs. MRNA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bio-Techne Corporation (TECH) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TECH vs. MRNA - Dividend Comparison
TECH's dividend yield for the trailing twelve months is around 0.67%, while MRNA has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TECH Bio-Techne Corporation | 0.67% | 0.44% | 0.41% | 0.77% | 0.25% | 0.40% | 0.58% | 0.88% | 0.99% | 1.24% | 1.42% | 1.35% |
MRNA Moderna, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
TECH vs. MRNA - Drawdown Comparison
The maximum TECH drawdown since its inception was -74.39%, smaller than the maximum MRNA drawdown of -94.94%. Use the drawdown chart below to compare losses from any high point for TECH and MRNA. For additional features, visit the drawdowns tool.
Volatility
TECH vs. MRNA - Volatility Comparison
The current volatility for Bio-Techne Corporation (TECH) is 19.31%, while Moderna, Inc. (MRNA) has a volatility of 21.83%. This indicates that TECH experiences smaller price fluctuations and is considered to be less risky than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
TECH vs. MRNA - Financials Comparison
This section allows you to compare key financial metrics between Bio-Techne Corporation and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities